About Juehn-Shin Maa
Form D filings for Maxim Biomedical in 2024 list Juehn-Shin Maa as chief operating officer and director.
Juehn-Shin Maa first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Juehn-Shin Maa in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Juehn-Shin Maa works with at each company, as listed on that company's latest Form D.
Maxim Biomedical, Inc. · Form D, Jun 5, 2024
JG
Jason Gray
Director
JM
Jonathan Maa
Chief Operating Officer and director